Memorial SloanKettering Cancer Center News
News on Memorial SloanKettering Cancer Center continually updated from thousands of sources around the net.
9 hrs ago | Biopharm
GlaxoSmithKline has formed the Oncology Clinical and Translational Consortium , a scientific research network comprised of six international cancer centers.
Whose policies do more to help the poor?
Do you support a federal assault weapons ban?
13 hrs ago | Business Journal
Less than two months after its IPO and nearly two years into commercialization, Foundation Medicine Inc. has rolled out a second diagnostic cancer test.
Dan Pelletier remembers some tense conversations in the JC Penney's junior department when he and his pre-teen daughter first shopped together for her clothes.
Foundation Medicine today announced new data demonstrating that its fully informative genomic profile for hematologic cancers, FoundationOne Heme, can be performed in routine clinical cancer specimens to identify all classes of genomic alterations, including gene fusions, across hundreds of genes related to oncogenesis in patients with hematologic ... (more)
For cancer patients, getting through the rigors of treatment is the first hurdle.
Some Americans won't have access to a number of the nation's top hospitals under the Affordable Care Act, according to Stephanie Kirchgaessner, Washington correspondent for The Financial Times.
We know that cancer is a personal disease, with each case displaying a unique genetic makeup that demands uniquely targeted therapy.
Cancer biologist Joan MassaguA© was appointed as head of the research arm of the Memorial Sloan-Kettering Cancer Center in New York last month.
Actinium Pharmaceuticals, Inc. , a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, were presented in a poster session on Saturday, December 7, 2013 at the American Society of Hematology's 55th Annual Meeting and Exposition in New Orleans.
Three years ago, University of Pennsylvania researchers wondered whether their early success with a novel immune therapy was the dawn of a revolution in cancer treatment, or a fluke.
Dr. Rossi is a research investigator at the Memorial Sloan-Kettering Cancer Center and is in private practice, both in New York, New York.
GlaxoSmithKline plc [LSE/NYSE: GSK] announced today the formation of the Oncology Clinical and Translational Consortium , a collaborative scientific research network comprised of six internationally renowned comprehensive cancer centres.
NEW YORK CITY - The James Blake Foundation brought tennis to New York's 69th Regiment Armory Thursday night for the 2013 edition of Serving for a Cure.